Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × T790M Positive NSCLC Patients × osimertinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 12 Lung Neoplasms 3 T790M Positive NSCLC Patients 1 Sexual Dysfunction, Physiological 1 NSCLC 1 Eunuchism 1 Erectile Dysfunction 1 EGF-R Positive Non-Small Cell Lung Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03133234 2018-11-20

Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

AstraZeneca

T790M Positive NSCLC Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡